What is Zofran?
Zofran, originally developed by GlaxoSmithKline and was marketed by them in 1991, was approved by the FDA to treat nausea in cancer patients undergoing chemotherapy and radiation treatment and for postoperative surgery patients. It has become one of the most prescribed drugs for nausea in the United States. Zofran is also known as Zuplenz.
Zofran Risk
$10.3 million Settlement for Missouri residents who purchased Celexa or Lexapro for a minor child.
Pendley, Baudin and Coffin helps to achieve $40 million class action settlement with GlaxoSmithKline. A federal judge in Minnesota approved the settlement to refund money to third party payors that paid for Paxil used by children.
From: HarrisMartin's Drugs & Medical Devices Publication
Date: July 17, 2014
www.harrismartin.com
W. Va. Federal Judge Strikes Forest Labs' Learned Intermediary
Defense in Lexapro Suicide Case
WHEELING, W. Va. - A West Virginia federal judge has granted a plaintiff's motion to strike a drug maker's learned intermediary defense in a Lexapro suicide case, noting the state's high court has expressly declined to adopt the learned intermediary doctrine.
Pendley, Baudin and Coffin, L.L.P. has been the first law firm to file a Lipitor suit in Louisiana; the firm has also filed a suit in South Carolina.
Lipitor, a cholesterol lowering statin medication, and its generic version atorvastatin have been linked to an increased risk for diabetes in women. Studies found that women aged of 50 to 79, who were taking Lipitor or the generic atorvastatin, were at a higher risk of developing Type 2 diabetes. Lipitor is produced and sold by Pfizer a pharmaceutical company.
Class Action Litigation Report
May 15, 2014
Pharmaceuticals
Hundreds of Women Sue Pfizer; Failure to Warn of Diabetes Risk Alleged
By Julie A. Steinberg
The FDA is investigating the risk of heart attack, stroke and death in men using FDA approved prescription testosterone products. A study by the National Cancer Institute and a study published in the Journal of The American Medical Association (JAMA), in November of 2013, prompted the FDA investigation. The studies showed that three months after beginning "low-T" treatments with testosterone therapy drugs, the risk of heart attack doubled among men over 65 and younger men with a history of heart disease.
Testosterone Replacement Therapy Side Effects:
Individual settlement in the amount of $300,000.00 for client injured after using a medication sold by an international pharmaceutical company.
Pendley, Baudin and Coffin, L.L.P. has been the first law firm to file a Lipitor suit in Louisiana; the firm has also filed a suit in South Carolina.
Lipitor, a cholesterol lowering statin medication, and its generic version atorvastatin have been linked to an increased risk for diabetes in women. Studies found that women aged of 50 to 79, who were taking Lipitor or the generic atorvastatin, were at a higher risk of developing Type 2 diabetes. Lipitor is produced and sold by Pfizer a pharmaceutical company.